Molecular patterns in the evolution of serrated lesion of the colorectum

International Journal of Cancer

Volumn 132, Issue 8, 2013, Pages 1800-1810

  Gaiser, Timo ^a,b   Meinhardt, Sandra ^a   Hirsch, Daniela ^a   Killian, Jonathan Keith ^a   Gaedcke, Jochen ^c   Jo, Peter ^c   Ponsa, Immaculada ^d   Mirõ, Rosa ^d   Rüschoff, Josef ^e   Seitz, Gerhard ^f   Hu, Yue ^a   Camps, Jordi ^a   Ried, Thomas ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

^d UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^e Institute of Pathology Nordhessen   (Germany)

^f Hospital of the Sozialstiftung Bamberg   (Germany)

Author keywords

colorectal cancer; HP; MSI; serrated polyps; SSA P; TSA

Indexed keywords

B RAF KINASE; DNA; K RAS PROTEIN; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; MISMATCH REPAIR PROTEIN PMS2; PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6;

ARTICLE; BRAF GENE; CHROMOSOMAL INSTABILITY; CHROMOSOME 8; CHROMOSOME LOSS; COLORECTAL ADENOMA; COLORECTAL CANCER; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; GENE MUTATION; GENETIC GAIN; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MICROSATELLITE INSTABILITY; MOLECULAR EVOLUTION; MUTATIONAL ANALYSIS; ONCOGENE; ONCOGENE K RAS; PI3K3CA GENE; PRIORITY JOURNAL; PROMOTER REGION; SEQUENCE ANALYSIS;

CHROMOSOME ABERRATIONS; COLORECTAL NEOPLASMS; COMPARATIVE GENOMIC HYBRIDIZATION; DNA METHYLATION; HUMANS; IMMUNOHISTOCHEMISTRY; MICROSATELLITE INSTABILITY; ONCOGENES; PARAFFIN EMBEDDING;

EID: 84873995588     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27869     Document Type: Article

References (49)

1. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
2. Georgiades IB, Curtis LJ, Morris RM, et al. Heterogeneity studies identify a subset of sporadic colorectal cancers without evidence for chromosomal or microsatellite instability. Oncogene 1999; 18: 7933-40.
3. Toyota M, Ahuja N, Ohe-Toyota M, et al. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci USA 1999; 96: 8681-6.
4. Bosman FT, Carneiro F, Hruban RH, et al. WHO classification of tumours of the Digestive System, 2010/12/22 4th Edition ed. Lyon: WHO PRESS, 2010.
5. Jass JR,. Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology 2007; 50: 113-30.
6. Issa JP,. Colon cancer: it's CIN or CIMP. Clin Cancer Res 2008; 14: 5939-40.
7. Kondo Y, Issa JP,. Epigenetic changes in colorectal cancer. Cancer Metastasis Rev 2004; 23: 29-39.
8. Olsen HW, Lawrence WA, Snook CW, et al. Risk factors and screening techniques in 500 patients with benign and malignant colon polyps. An urban community experience. Dis Colon Rectum 1988; 31: 216-21.
9. Makinen MJ,. Colorectal serrated adenocarcinoma. Histopathology 2007; 50: 131-50.
10. Jones PA, Baylin SB,. The epigenomics of cancer. Cell 2007; 128: 683-92.
11. Snover DC, Jass JR, Fenoglio-Preiser C, et al. Serrated polyps of the large intestine: a morphologic and molecular review of an evolving concept. Am J Clin Pathol 2005; 124: 380-91.
12. O'Brien MJ, Winawer SJ, Zauber AG, et al. The National Polyp Study. Patient and polyp characteristics associated with high-grade dysplasia in colorectal adenomas. Gastroenterology 1990; 98: 371-9.
13. Gaiser T, Camps J, Meinhardt S, et al. Genome and transcriptome profiles of CD133-positive colorectal cancer cells. Am J Pathol 2011; 178: 1478-88.
14. Jo P, Jung K, Grade M, et al. CpG island methylator phenotype infers a poor disease-free survival in locally advanced rectal cancer. Surgery 2012; 151: 564-70.
15. Ruschoff J, Bocker T, Schlegel J, et al. Microsatellite instability: new aspects in the carcinogenesis of colorectal carcinoma. Virchows Arch 1995; 426: 215-22.
16. Bibikova M, Fan JB,. GoldenGate assay for DNA methylation profiling. Methods Mol Biol 2009; 507: 149-63.
17. Weisenberger DJ, Siegmund KD, Campan M, et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 2006; 38: 787-93.
18. Camps J, Grade M, Nguyen QT, et al. Chromosomal breakpoints in primary colon cancer cluster at sites of structural variants in the genome. Cancer Res 2008; 68: 1284-95.
19. Hermsen M, Postma C, Baak J, et al. Colorectal adenoma to carcinoma progression follows multiple pathways of chromosomal instability. Gastroenterology 2002; 123: 1109-19.
20. Ghadimi BM, Sackett DL, Difilippantonio MJ, et al. Centrosome amplification and instability occurs exclusively in aneuploid, but not in diploid colorectal cancer cell lines, and correlates with numerical chromosomal aberrations. Genes Chromosomes Cancer 2000; 27: 183-90.
21. Ried T, Knutzen R, Steinbeck R, et al. Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors. Genes Chromosomes Cancer 1996; 15: 234-45.
22. Petko Z, Ghiassi M, Shuber A, et al. Aberrantly methylated CDKN2A, MGMT, and MLH1 in colon polyps and in fecal DNA from patients with colorectal polyps. Clin Cancer Res 2005; 11: 1203-9.
23. Esteller M, Toyota M, Sanchez-Cespedes M, et al. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis. Cancer Res 2000; 60: 2368-71.
24. Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal-tumor development. N Engl J Med 1988; 319: 525-32.
25. Meijer GA, Hermsen MA, Baak JP, et al. Progression from colorectal adenoma to carcinoma is associated with non-random chromosomal gains as detected by comparative genomic hybridisation. J Clin Pathol 1998; 51: 901-9.
26. Bardi G, Fenger C, Johansson B, et al. Tumor karyotype predicts clinical outcome in colorectal cancer patients. J Clin Oncol 2004; 22: 2623-34.
27. Chan TL, Zhao W, Leung SY, et al. BRAF and KRAS mutations in colorectal hyperplastic polyps and serrated adenomas. Cancer Res 2003; 63: 4878-81.
28. McLellan EA, Owen RA, Stepniewska KA, et al. High frequency of K-ras mutations in sporadic colorectal adenomas. Gut 1993; 34: 392-6.
29. Yang S, Farraye FA, Mack C, et al. BRAF and KRAS Mutations in hyperplastic polyps and serrated adenomas of the colorectum: relationship to histology and CpG island methylation status. Am J Surg Pathol 2004; 28: 1452-9.
30. Rosty C, Buchanan DD, Walsh MD, et al. Phenotype and polyp landscape in serrated polyposis syndrome: a series of 100 patients from genetics clinics. Am J Surg Pathol 2012; 36: 876-82.
31. Hawkins N, Norrie M, Cheong K, et al. CpG island methylation in sporadic colorectal cancers and its relationship to microsatellite instability. Gastroenterology 2002; 122: 1376-87.
32. Cantley LC,. The phosphoinositide 3-kinase pathway. Science 2002; 296: 1655-7.
33. Velho S, Oliveira C, Ferreira A, et al. The prevalence of PIK3CA mutations in gastric and colon cancer. Eur J Cancer 2005; 41: 1649-54.
34. Middeldorp A, van Eijk R, Oosting J, et al. Increased frequency of 20q gain and copy-neutral loss of heterozygosity in mismatch repair proficient familial colorectal carcinomas. Int J Cancer 2012; 130: 837-46.
35. Ortega P, Moran A, de Juan C, et al. Differential Wnt pathway gene expression and E-cadherin truncation in sporadic colorectal cancers with and without microsatellite instability. Clin Cancer Res 2008; 14: 995-1001.
36. Leslie A, Stewart A, Baty DU, et al. Chromosomal changes in colorectal adenomas: relationship to gene mutations and potential for clinical utility. Genes Chromosomes Cancer 2006; 45: 126-35.
37. Smith G, Carey FA, Beattie J, et al. Mutations in APC, Kirsten-ras, and p53 - alternative genetic pathways to colorectal cancer. Proc Natl Acad Sci USA 2002; 99: 9433-8.
38. Marusyk A, Polyak K,. Tumor heterogeneity: causes and consequences. Biochim Biophys Acta 2010; 1805: 105-17.
39. Camps J, Armengol G, del Rey J, et al. Genome-wide differences between microsatellite stable and unstable colorectal tumors. Carcinogenesis 2006; 27: 419-28.
40. Douglas EJ, Fiegler H, Rowan A, et al. Array comparative genomic hybridization analysis of colorectal cancer cell lines and primary carcinomas. Cancer Res 2004; 64: 4817-25.
41. Trautmann K, Terdiman JP, French AJ, et al. Chromosomal instability in microsatellite-unstable and stable colon cancer. Clin Cancer Res 2006; 12: 6379-85.
42. Ghadimi BM, Grade M, Liersch T, et al. Gain of chromosome 8q23-24 is a predictive marker for lymph node positivity in colorectal cancer. Clin Cancer Res 2003; 9: 1808-14.
43. Sayagues JM, Fontanillo C, Abad Mdel M, et al. Mapping of genetic abnormalities of primary tumours from metastatic CRC by high-resolution SNP arrays. PLoS One 2010; 5: e13752.
44. Elsaleh H, Powell B, McCaul K, et al. P53 alteration and microsatellite instability have predictive value for survival benefit from chemotherapy in stage III colorectal carcinoma. Clin Cancer Res 2001; 7: 1343-9.
45. Halling KC, French AJ, McDonnell SK, et al. Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers. J Natl Cancer Inst 1999; 91: 1295-303.
46. Hemminki A, Mecklin JP, Jarvinen H, et al. Microsatellite instability is a favorable prognostic indicator in patients with colorectal cancer receiving chemotherapy. Gastroenterology 2000; 119: 921-8.
47. Wright CM, Dent OF, Barker M, et al. Prognostic significance of extensive microsatellite instability in sporadic clinicopathological stage C colorectal cancer. Br J Surg 2000; 87: 1197-202.
48. Malesci A, Laghi L, Bianchi P, et al. Reduced likelihood of metastases in patients with microsatellite-unstable colorectal cancer. Clin Cancer Res 2007; 13: 3831-9.
49. Cheng YW, Pincas H, Bacolod MD, et al. CpG island methylator phenotype associates with low-degree chromosomal abnormalities in colorectal cancer. Clin Cancer Res 2008; 14: 6005-13.